Yasser Heakal
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Lipid Membrane Structure and Behavior, Autophagy in Disease and Therapy, Cancer Research and Treatments, Receptor Mechanisms and Signaling
Most-Cited Works
- → Calcium Phosphate Nanocomposite Particles for In Vitro Imaging and Encapsulated Chemotherapeutic Drug Delivery to Cancer Cells(2008)270 cited
- → Rapid Distribution of Liposomal Short-Chain Ceramide in Vitro and in Vivo(2008)77 cited
- → Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer(2011)65 cited
- → Vemurafenib (PLX4032): An Orally Available Inhibitor of Mutated BRAF for the Treatment of Metastatic Melanoma(2011)53 cited
- → Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains(2011)38 cited
- → Nanoliposomal Short-Chain Ceramide Inhibits Agonist-Dependent Translocation of Neurotensin Receptor 1 to Structured Membrane Microdomains in Breast Cancer Cells(2009)25 cited
- → LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of Apoptosis and Necroptosis(2018)21 cited
- → Abstract 4281: LT-IIc, a bacterial type II heat-labile enterotoxin, induces specific lethality in triple negative breast cancer cells by modulaton of autophagy and induction of apoptosis and necroptosis(2019)1 cited
- → Supplementary Data from Nanoliposomal Short-Chain Ceramide Inhibits Agonist-Dependent Translocation of Neurotensin Receptor 1 to Structured Membrane Microdomains in Breast Cancer Cells(2023)
- IDENTIFICATION OF NOVEL PHARMACOLOGICAL APPROACHES TO INHIBITNEUROTENSIN RECEPTOR-1 MITOGENIC SIGNALING IN BREAST CANCERCELLS(2009)